great result stockrock with both primary end points met. was also very pleased with the results for the secondary endpoints as these positively impact patient perception of treatment and prevention. looks like a very promising second half for SPL.
- Forums
- ASX - By Stock
- FDA Phase 3 passed!! Amazing!!
great result stockrock with both primary end points met. was...
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.6¢ |
Change
0.001(1.05%) |
Mkt cap ! $40.06M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.6¢ | $12.27K | 126.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3994 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 6291 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3994 | 0.096 |
2 | 89646 | 0.095 |
2 | 305855 | 0.094 |
2 | 320000 | 0.093 |
1 | 100000 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 6291 | 1 |
0.098 | 200000 | 1 |
0.099 | 35051 | 1 |
0.100 | 106000 | 3 |
0.105 | 143467 | 2 |
Last trade - 13.38pm 09/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |